Top compounds associated with response to RGPD5


Feature Type Standardized
Nominal ANOVA
mRNA HC-067047 CTRPv2 pan-cancer AAC -0.08 0.06
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.074 0.06
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.076 0.06
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.072 0.07
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.071 0.07
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.072 0.07
mRNA BRD-K33199242 CTRPv2 pan-cancer AAC -0.075 0.07
mRNA KU-55933 CTRPv2 pan-cancer AAC -0.072 0.07
mRNA sitagliptin CTRPv2 pan-cancer AAC -0.15 0.07
mRNA Bexarotene CTRPv2 pan-cancer AAC -0.07 0.08
Download CSV